Arkolith/Insider Trading/ARTL/Form 4

Spring Mark Edward

Chief Financial OfficerARTELO BIOSCIENCES, INC. (ARTL) · full profile →Form 4 · filed Feb 2, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 29, 2026Grant(A)36K—$036K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001640334-26-000193) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML